During the past decade, Amarillo Center For Clinical Research conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 14 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amarillo Center For Clinical Research" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amarillo Center For Clinical Research" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Amarillo Center For Clinical Research" are "Rheumatoid Arthritis" (14 trials), "Systemic Lupus Erythematosus" (6 trials), "Lupus Erythematosus, Systemic" (2 trials), "Lupus Nephritis" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Amarillo Center For Clinical Research" in a lesser frequency.

Most popular intervention types in "Amarillo Center For Clinical Research" are "Drug" (30 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Baricitinib" (3 trials), "Methotrexate" (3 trials), "Methylprednisolone" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Amarillo Center For Clinical Research" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Amarillo Center For Clinical Research". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Amarillo Center For Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Amarillo Center For Clinical Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".